{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:47:00Z","timestamp":1793191620232,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e34854","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T21:38:15Z","timestamp":1721252295000},"page":"e34854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stiripentol efficacy against status epilepticus and associated mortality in mice"],"prefix":"10.1016","volume":"10","author":[{"given":"P.","family":"Girard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cloarec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Verleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Castagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34854_bib1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/dmcn.15638","article-title":"Initiating stiripentol before 2 years of age in patients with Dravet syndrome is safe and beneficial against status epilepticus","volume":"65","author":"Chiron","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.heliyon.2024.e34854_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ane.12403","article-title":"Stiripentol for the treatment of super-refractory status epilepticus","volume":"132","author":"Strzelczyk","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.heliyon.2024.e34854_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ane.12888","article-title":"Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity","volume":"137","author":"Uchida","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.heliyon.2024.e34854_bib4","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/epi.12401","article-title":"Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain","volume":"54","author":"Auvin","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2012.11.002","article-title":"Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus","volume":"67","author":"Grosenbaugh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e34854_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2174\/092986709787549316","article-title":"Epilepsy, regulation of brain energy metabolism and neurotransmission","volume":"16","author":"Cloix","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e34854_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2990.1985.tb00010.x","article-title":"Glycogen content and fructose-1, 6-biphosphatase activity in methionine sulfoximine epileptogenic mouse brain and liver after protein synthesis inhibition","volume":"11","author":"Hevor","year":"1985","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e34854_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0024-3205(00)00756-6","article-title":"Correlation between brain glycogen and convulsive state in mice submitted to methionine sulfoximine","volume":"67","author":"Bernard-Helary","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e34854_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/epi4.12569","article-title":"Guidance on Dravet syndrome from infant to adult care: road map for treatment planning in Europe","volume":"7","author":"Cardenal-Mu\u00f1oz","year":"2022","journal-title":"Epilepsia open"},{"key":"10.1016\/j.heliyon.2024.e34854_bib10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/epi.17274","article-title":"International consensus on diagnosis and management of Dravet syndrome","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1528-1167.2009.02200.x","article-title":"Selection of two lines of mice based on latency to onset of methionine sulfoximine seizures","volume":"51","author":"Cloix","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib12","first-page":"858","article-title":"Effect of combined treatment of thioperamide with some antiepileptic drugs on methionine-sulfoximine induced convulsions in mice","volume":"48","author":"Vohora","year":"2010","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.heliyon.2024.e34854_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neures.2011.03.002","article-title":"Serotonergic neurotransmission plays a major role in the action of the glycogenic convulsant methionine sulfoximine","volume":"70","author":"Picard","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.heliyon.2024.e34854_bib14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s12325-024-02813-0","article-title":"An update on stiripentol mechanisms of action: a narrative review","volume":"41","author":"Bacq","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.heliyon.2024.e34854_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.06.004","article-title":"The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator","volume":"56","author":"Fisher","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e34854_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1528-1167.2006.00497.x","article-title":"Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels","volume":"47","author":"Quilichini","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1167.2007.01337.x","article-title":"Impact of receptor changes on treatment of status epilepticus","volume":"48 S8","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jnr.23688","article-title":"Neuroprotective activity of stiripentol with a possible involvement of voltage-dependent calcium and sodium channels","volume":"94","author":"Verleye","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.heliyon.2024.e34854_bib19","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/epi.17201","article-title":"Stiripentol inhibits spike-and-wave discharges in animal models of absence seizures. A new mechanism of action involving T-type calcium channels","volume":"63","author":"Riban","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.aaa1299","article-title":"Epilepsy treatment. Targeting LDH enzymes with stiripentol analog to treat epilepsy","volume":"347","author":"Sada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e34854_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jnr.490140407","article-title":"Cerebral citric acid cycle enzymes in methionine sulfoximine toxicity","volume":"14","author":"Ratnakumari","year":"1985","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.heliyon.2024.e34854_bib22","first-page":"324","article-title":"The effect of sodium benzoate, L-carnitine, and phenylacetate on valproate-induced hyperammonemia in Male Wistar rats","volume":"14","author":"Etemad","year":"2022","journal-title":"International journal of physiology, pathophysiology and pharmacology"},{"key":"10.1016\/j.heliyon.2024.e34854_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/jcp-2022-208644","article-title":"Drug-induced hyperammonaemia","volume":"76","author":"Shakerdi","year":"2023","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2024.e34854_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2014.09.002","article-title":"Ammonia metabolism and hyperammonemic disorders","volume":"67","author":"Walker","year":"2014","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.heliyon.2024.e34854_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100759","article-title":"Chronic valproic acid administration increases plasma, liver, and brain ammonia concentration and suppresses glutamine synthetase activity","volume":"10","author":"Badawy","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.heliyon.2024.e34854_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12611","article-title":"Audit of use of stiripentol in adults with Dravet syndrome","volume":"135","author":"Balestrini","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.heliyon.2024.e34854_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/epi.12303","article-title":"Stiripentol in Dravet syndrome: results of a retrospective U.S. study","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0883073818811538","article-title":"Efficacy of stiripentol and the clinical outcome in Dravet syndrome","volume":"34","author":"Yildiz","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.heliyon.2024.e34854_bib29","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/epi.16382","article-title":"Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature","volume":"60","author":"Fechner","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.9740\/mhc.2018.05.148","article-title":"Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: a case series and literature review","volume":"8","author":"Brown","year":"2018","journal-title":"The mental health clinician"},{"key":"10.1016\/j.heliyon.2024.e34854_bib31","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/epi.16684","article-title":"Starting stiripentol in adults with Dravet syndrome? Watch for ammonia and carnitine","volume":"61","author":"Zulfiqar Ali","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.heliyon.2024.e34854_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024108857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024108857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:58:02Z","timestamp":1784066282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024108857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024108857"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34854","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stiripentol efficacy against status epilepticus and associated mortality in mice","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34854"}}